[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Tyrosine Kinase JAK Inhibitors Market Data Survey Report 2015-2025

February 2020 | 62 pages | ID: G020E359D47DEN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
The global Tyrosine Kinase JAK Inhibitors market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including:

Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type

Key manufacturers are included based on company profile, sales data and product specifications etc.:
  • Pfizer
  • Incyte
  • Novartis
  • Eli Lilly
  • Gilead
  • Sanofi
  • Galapagos
  • AbbVie
  • Vertex
  • Teva
  • Astellas Pharma
  • Celgene
  • CTI BioPharma
Major applications as follows:
  • Rheumatoid Arthritis (RA)
  • Polycythemia Vera (PCV)
  • Myelofibrosis (MF)
  • Others
Major Type as follows:
  • Tofacitinib
  • Ruxolitinib
  • Baricitinib
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of End-Use
  1.1.4 Scope of Product Type
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size
Fig Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2020-2025 (Volume)

2 REGIONAL MARKET

2.1 Regional Sales
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
2.2 Regional Demand
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
2.3 Regional Trade
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)

3 KEY MANUFACTURERS

3.1 Pfizer
  3.1.1 Company Information
Tab Company Profile List of Pfizer
  3.1.2 Product & Services
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Pfizer
  3.1.4 Recent Development
3.2 Incyte
  3.2.1 Company Information
Tab Company Profile List of Incyte
  3.2.2 Product & Services
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Incyte
  3.2.4 Recent Development
3.3 Novartis
  3.3.1 Company Information
Tab Company Profile List of Novartis
  3.3.2 Product & Services
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis
  3.3.4 Recent Development
3.4 Eli Lilly
  3.4.1 Company Information
Tab Company Profile List of Eli Lilly
  3.4.2 Product & Services
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eli Lilly
  3.4.4 Recent Development
3.5 Gilead
  3.5.1 Company Information
Tab Company Profile List of Gilead
  3.5.2 Product & Services
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Gilead
  3.5.4 Recent Development
3.6 Sanofi
  3.6.1 Company Information
Tab Company Profile List of Sanofi
  3.6.2 Product & Services
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sanofi
  3.6.4 Recent Development
3.7 Galapagos
  3.7.1 Company Information
Tab Company Profile List of Galapagos
  3.7.2 Product & Services
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Galapagos
  3.7.4 Recent Development
3.8 AbbVie
  3.8.1 Company Information
Tab Company Profile List of AbbVie
  3.8.2 Product & Services
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of AbbVie
  3.8.4 Recent Development
3.9 Vertex
  3.9.1 Company Information
Tab Company Profile List of Vertex
  3.9.2 Product & Services
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Vertex
  3.9.4 Recent Development
3.10 Teva
  3.10.1 Company Information
Tab Company Profile List of Teva
  3.10.2 Product & Services
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva
  3.10.4 Recent Development
3.11 Astellas Pharma
  3.11.1 Company Information
Tab Company Profile List of Astellas Pharma
  3.11.2 Product & Services
  3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Astellas Pharma
  3.11.4 Recent Development
3.12 Celgene
  3.12.1 Company Information
Tab Company Profile List of Celgene
  3.12.2 Product & Services
  3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Celgene
3.13 CTI BioPharma
  3.13.1 Company Information
Tab Company Profile List of CTI BioPharma
  3.13.2 Product & Services
  3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of CTI BioPharma

4 MAJOR END-USE

4.1 Rheumatoid Arthritis (RA)
  4.1.1 Overview
Tab Summary of Consumption Distribution of Rheumatoid Arthritis (RA)
  4.1.2 Rheumatoid Arthritis (RA) Market Size and Forecast
Fig Rheumatoid Arthritis (RA) Market Size and CAGR 2015-2019 (Million USD)
Fig Rheumatoid Arthritis (RA) Market Size and CAGR 2015-2019 (Volume)
Fig Rheumatoid Arthritis (RA) Market Forecast and CAGR 2020-2025 (Million USD)
Fig Rheumatoid Arthritis (RA) Market Forecast and CAGR 2020-2025 (Volume)
4.2 Polycythemia Vera (PCV)
  4.2.1 Overview
Tab Summary of Consumption Distribution of Polycythemia Vera (PCV)
  4.2.2 Polycythemia Vera (PCV) Market Size and Forecast
Fig Polycythemia Vera (PCV) Market Size and CAGR 2015-2019 (Million USD)
Fig Polycythemia Vera (PCV) Market Size and CAGR 2015-2019 (Volume)
Fig Polycythemia Vera (PCV) Market Forecast and CAGR 2020-2025 (Million USD)
Fig Polycythemia Vera (PCV) Market Forecast and CAGR 2020-2025 (Volume)
4.3 Myelofibrosis (MF)
  4.3.1 Overview
Tab Summary of Consumption Distribution of Myelofibrosis (MF)
  4.3.2 Myelofibrosis (MF) Market Size and Forecast
Fig Myelofibrosis (MF) Market Size and CAGR 2015-2019 (Million USD)
Fig Myelofibrosis (MF) Market Size and CAGR 2015-2019 (Volume)
Fig Myelofibrosis (MF) Market Forecast and CAGR 2020-2025 (Million USD)
Fig Myelofibrosis (MF) Market Forecast and CAGR 2020-2025 (Volume)
4.4 Others
  4.4.1 Overview
Tab Summary of Consumption Distribution of Others
  4.4.2 Others Market Size and Forecast
Fig Others Market Size and CAGR 2015-2019 (Million USD)
Fig Others Market Size and CAGR 2015-2019 (Volume)
Fig Others Market Forecast and CAGR 2020-2025 (Million USD)
Fig Others Market Forecast and CAGR 2020-2025 (Volume)

5 MARKET BY TYPE

5.1 Tofacitinib
  5.1.1 Overview
Tab Product Overview of Tofacitinib
  5.1.2 Tofacitinib Market Size and Forecast
Fig Tofacitinib Market Size and CAGR 2015-2019 (Million USD)
Fig Tofacitinib Market Size and CAGR 2015-2019 (Volume)
Fig Tofacitinib Market Forecast and CAGR 2020-2025 (Million USD)
Fig Tofacitinib Market Forecast and CAGR 2020-2025 (Volume)
5.2 Ruxolitinib
  5.2.1 Overview
Tab Product Overview of Ruxolitinib
  5.2.2 Ruxolitinib Market Size and Forecast
Fig Ruxolitinib Market Size and CAGR 2015-2019 (Million USD)
Fig Ruxolitinib Market Size and CAGR 2015-2019 (Volume)
Fig Ruxolitinib Market Forecast and CAGR 2020-2025 (Million USD)
Fig Ruxolitinib Market Forecast and CAGR 2020-2025 (Volume)
5.3 Baricitinib
  5.3.1 Overview
Tab Product Overview of Baricitinib
  5.3.2 Baricitinib Market Size and Forecast
Fig Baricitinib Market Size and CAGR 2015-2019 (Million USD)
Fig Baricitinib Market Size and CAGR 2015-2019 (Volume)
Fig Baricitinib Market Forecast and CAGR 2020-2025 (Million USD)
Fig Baricitinib Market Forecast and CAGR 2020-2025 (Volume)

6 PRICE OVERVIEW

6.1 Price by Manufacturers
Tab Different Products Prices List of Major Manufacturers
6.2 Price by End-Use
Tab Different Products Prices List of End-Use
6.3 Price by Type
Tab Different Products Prices List of Produt Type

7 CONCLUSION

LIST OF TABLES

Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
Tab Company Profile List of Pfizer
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Pfizer
Tab Company Profile List of Incyte
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Incyte
Tab Company Profile List of Novartis
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis
Tab Company Profile List of Eli Lilly
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eli Lilly
Tab Company Profile List of Gilead
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Gilead
Tab Company Profile List of Sanofi
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sanofi
Tab Company Profile List of Galapagos
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Galapagos
Tab Company Profile List of AbbVie
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of AbbVie
Tab Company Profile List of Vertex
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Vertex
Tab Company Profile List of Teva
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva
Tab Company Profile List of Astellas Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Astellas Pharma
Tab Company Profile List of Celgene
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Celgene
Tab Company Profile List of CTI BioPharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of CTI BioPharma
Tab Summary of Consumption Distribution of Rheumatoid Arthritis (RA)
Tab Summary of Consumption Distribution of Polycythemia Vera (PCV)
Tab Summary of Consumption Distribution of Myelofibrosis (MF)
Tab Summary of Consumption Distribution of Others
Tab Product Overview of Tofacitinib
Tab Product Overview of Ruxolitinib
Tab Product Overview of Baricitinib
Tab Different Products Prices List of Major Manufacturers
Tab Different Products Prices List of End-Use
Tab Different Products Prices List of Produt Type

LIST OF FIGURES

Fig Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2020-2025 (Volume)
Fig Rheumatoid Arthritis (RA) Market Size and CAGR 2015-2019 (Million USD)
Fig Rheumatoid Arthritis (RA) Market Size and CAGR 2015-2019 (Volume)
Fig Rheumatoid Arthritis (RA) Market Forecast and CAGR 2020-2025 (Million USD)
Fig Rheumatoid Arthritis (RA) Market Forecast and CAGR 2020-2025 (Volume)
Fig Polycythemia Vera (PCV) Market Size and CAGR 2015-2019 (Million USD)
Fig Polycythemia Vera (PCV) Market Size and CAGR 2015-2019 (Volume)
Fig Polycythemia Vera (PCV) Market Forecast and CAGR 2020-2025 (Million USD)
Fig Polycythemia Vera (PCV) Market Forecast and CAGR 2020-2025 (Volume)
Fig Myelofibrosis (MF) Market Size and CAGR 2015-2019 (Million USD)
Fig Myelofibrosis (MF) Market Size and CAGR 2015-2019 (Volume)
Fig Myelofibrosis (MF) Market Forecast and CAGR 2020-2025 (Million USD)
Fig Myelofibrosis (MF) Market Forecast and CAGR 2020-2025 (Volume)
Fig Others Market Size and CAGR 2015-2019 (Million USD)
Fig Others Market Size and CAGR 2015-2019 (Volume)
Fig Others Market Forecast and CAGR 2020-2025 (Million USD)
Fig Others Market Forecast and CAGR 2020-2025 (Volume)
Fig Tofacitinib Market Size and CAGR 2015-2019 (Million USD)
Fig Tofacitinib Market Size and CAGR 2015-2019 (Volume)
Fig Tofacitinib Market Forecast and CAGR 2020-2025 (Million USD)
Fig Tofacitinib Market Forecast and CAGR 2020-2025 (Volume)
Fig Ruxolitinib Market Size and CAGR 2015-2019 (Million USD)
Fig Ruxolitinib Market Size and CAGR 2015-2019 (Volume)
Fig Ruxolitinib Market Forecast and CAGR 2020-2025 (Million USD)
Fig Ruxolitinib Market Forecast and CAGR 2020-2025 (Volume)
Fig Baricitinib Market Size and CAGR 2015-2019 (Million USD)
Fig Baricitinib Market Size and CAGR 2015-2019 (Volume)
Fig Baricitinib Market Forecast and CAGR 2020-2025 (Million USD)
Fig Baricitinib Market Forecast and CAGR 2020-2025 (Volume)


More Publications